A. Katrukha

928 total citations
17 papers, 740 citations indexed

About

A. Katrukha is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, A. Katrukha has authored 17 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 6 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Oncology. Recurrent topics in A. Katrukha's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Acute Myocardial Infarction Research (4 papers) and Trace Elements in Health (2 papers). A. Katrukha is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Acute Myocardial Infarction Research (4 papers) and Trace Elements in Health (2 papers). A. Katrukha collaborates with scholars based in Russia, Finland and Tajikistan. A. Katrukha's co-authors include Nikolai B. Gusev, Vladimir Vladimirovich Filatov, A. Bereznikova, Tatiana V Esakova, T.V. Bulargina, Kim Pettersson, Kari Pulkki, Timo Lövgren, N. A. Gratsiansky and Liisa‐Maria Voipio‐Pulkki and has published in prestigious journals such as FEBS Letters, Clinical Chemistry and Scandinavian Journal of Clinical and Laboratory Investigation.

In The Last Decade

A. Katrukha

17 papers receiving 710 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Katrukha Russia 10 509 212 189 89 61 17 740
Tatiana V Esakova Russia 6 485 1.0× 164 0.8× 106 0.6× 95 1.1× 75 1.2× 7 608
A. Bereznikova Russia 12 635 1.2× 262 1.2× 163 0.9× 137 1.5× 90 1.5× 26 844
Naveed Akhtar United States 11 158 0.3× 228 1.1× 87 0.5× 50 0.6× 10 0.2× 40 607
J. Albers Germany 14 159 0.3× 45 0.2× 335 1.8× 504 5.7× 143 2.3× 16 1.1k
Mindy L. Rawlins United States 12 101 0.2× 33 0.2× 144 0.8× 42 0.5× 12 0.2× 17 542
Rebecca Slater United States 9 688 1.4× 71 0.3× 300 1.6× 104 1.2× 20 0.3× 14 930
Ryo Kawamura Japan 20 949 1.9× 371 1.8× 321 1.7× 104 1.2× 7 0.1× 37 1.4k
Glenn S. Slavin United States 12 315 0.6× 384 1.8× 105 0.6× 96 1.1× 5 0.1× 27 777
B.A. Rhodes United States 11 49 0.1× 217 1.0× 102 0.5× 116 1.3× 22 0.4× 29 578
Kornélia Jaquet Germany 23 966 1.9× 34 0.2× 635 3.4× 57 0.6× 42 0.7× 45 1.2k

Countries citing papers authored by A. Katrukha

Since Specialization
Citations

This map shows the geographic impact of A. Katrukha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Katrukha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Katrukha more than expected).

Fields of papers citing papers by A. Katrukha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Katrukha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Katrukha. The network helps show where A. Katrukha may publish in the future.

Co-authorship network of co-authors of A. Katrukha

This figure shows the co-authorship network connecting the top 25 collaborators of A. Katrukha. A scholar is included among the top collaborators of A. Katrukha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Katrukha. A. Katrukha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Katrukha, A., et al.. (2019). Neutral Endopeptidase (Neprilysin) in Therapy and Diagnostics: Yin and Yang. Biochemistry (Moscow). 84(11). 1346–1358. 21 indexed citations
2.
Postnikov, Alexander B., Daria V. Serebryanaya, Stanislav V. Kozlovsky, et al.. (2012). N-terminal and C-terminal fragments of IGFBP-4 as novel biomarkers for short-term risk assessment of major adverse cardiac events in patients presenting with ischemia. Clinical Biochemistry. 45(7-8). 519–524. 34 indexed citations
3.
Serebryanaya, Daria V., et al.. (2010). Generation of recombinant antibodies and means for increasing their affinity. Biochemistry (Moscow). 75(13). 1584–1605. 23 indexed citations
4.
Koshkina, Ekaterina V, et al.. (2010). [Diagnostic value of cardiac troponin T increase in critically ill patients].. PubMed. 42–6. 1 indexed citations
5.
Katrukha, A., et al.. (2009). [Admission and predischarge levels of NT pre brain natriuretic peptide in patients hospitalized because of worsening heart failure. relation to risk of death in the next 6-12 months].. PubMed. 49(1). 34–8. 1 indexed citations
6.
Kogan, Alexander E, et al.. (2007). Comparison of soluble and placental transferrin receptors as standards for the determination of soluble transferrin receptor in humans. International Journal of Laboratory Hematology. 29(5). 335–340. 8 indexed citations
7.
Katrukha, A., et al.. (2006). [Levels of fatty acid binding protein before and after direct current cardioversion of atrial fibrillation or flutter in patients without acute coronary syndrome].. PubMed. 46(3). 43–8. 1 indexed citations
8.
Kogan, Alexander E, et al.. (2005). Immunological study of complex formation between soluble transferrin receptor and transferrin. American Journal of Hematology. 79(4). 281–287. 5 indexed citations
9.
Katrukha, A., A. Bereznikova, Vladimir Vladimirovich Filatov, & Tatiana V Esakova. (1999). Biochemical Factors Influencing Measurement of Cardiac Troponin I in Serum. Clinical Chemistry and Laboratory Medicine (CCLM). 37(11-12). 1091–1095. 60 indexed citations
10.
Filatov, Vladimir Vladimirovich, A. Katrukha, T.V. Bulargina, & Nikolai B. Gusev. (1999). Troponin: structure, properties, and mechanism of functioning.. PubMed. 64(9). 969–85. 134 indexed citations
11.
Katrukha, A., et al.. (1999). New approach to standardisation of human cardiac Troponin I (cTnI). Scandinavian Journal of Clinical and Laboratory Investigation. 59. 124–127. 10 indexed citations
12.
Katrukha, A., A. Bereznikova, & Kim Pettersson. (1999). New approach to standardisation of human cardiac Troponin I (cTnI). Scandinavian Journal of Clinical and Laboratory Investigation. 59(sup230). 124–127. 19 indexed citations
13.
Filatov, Vladimir Vladimirovich, A. Katrukha, A. Bereznikova, et al.. (1998). Epitope mapping of anti‐troponin I monoclonal antibodies. IUBMB Life. 45(6). 1179–1187. 15 indexed citations
14.
Katrukha, A., A. Bereznikova, Vladimir Vladimirovich Filatov, et al.. (1998). Degradation of cardiac troponin I: implication for reliable immunodetection. Clinical Chemistry. 44(12). 2433–2440. 186 indexed citations
15.
Katrukha, A., A. Bereznikova, Tatiana V Esakova, et al.. (1997). Troponin I is released in bloodstream of patients with acute myocardial infarction not in free form but as complex. Clinical Chemistry. 43(8). 1379–1385. 214 indexed citations
16.
Katrukha, A., A. Bereznikova, Tatiana V Esakova, et al.. (1995). A new method of human cardiac troponin I and troponin T purification.. PubMed. 36(1). 195–202. 5 indexed citations
17.
Katrukha, A., Natalia V. Bogatcheva, & Nikolai B. Gusev. (1993). Isolation of human cardiac troponin T and localization of epitopes recognized by monoclonal antibodies to cardiac troponin T. FEBS Letters. 315(1). 25–28. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026